Illumina Inc. stock falls Monday, underperforms market
Shares of Illumina Inc. ILMN, -2.18% shed 2.18% to $362.28 Monday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX, -0.14% falling 0.14% to 4,670.29…
From the Biotech Insider archive. This article dates from Jan 11, 2022 and is preserved as first published.
Shares of Illumina Inc. ILMN, -2.18% shed 2.18% to $362.28 Monday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX, -0.14% falling 0.14% to 4,670.29 and Dow Jones Industrial Average DJIA, -0.45% falling 0.45% to 36,068.87. This was the stock’s second consecutive day of losses. Illumina Inc. closed $193.49 below its 52-week high ($555.77), which the company achieved on February 12th.
28 Monday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX, -0.
The stock underperformed when compared to some of its competitors Monday, as Thermo Fisher Scientific Inc. TMO, +2.96% rose 2.96% to $625.04, Danaher Corp. DHR, +2.49% rose 2.49% to $303.03, and Agilent Technologies Inc. A, +0.01% rose 0.01% to $145.16. Trading volume (1.7 M) eclipsed its 50-day average volume of 917,929.
